个性化辅助噬菌体疗法治疗难治性骨科感染
Personalized adjunctive phage therapy for difficult-to-treat musculoskeletal infections
该研究开发了一种个性化辅助噬菌体疗法,用于治疗难治性骨科感染。研究团队从多个机构获得了噬菌体,并在KU Leuven获得了资助。该疗法在动物模型中显示出初步疗效,但仍需进一步临床验证。
Acknowledgements
The authors thank Charlotte Natens for her support during manuscript preparation. Phages were obtained through the Queen Astrid Military Hospital. We acknowledge Inteliphage (BE) for providing access to bacteriophage STA 2780 used in this study. We also thank the Eliava Institute of Bacteriophages, Microbiology and Virology (GE) for providing the bacteriophages ISP, PNM, PT07, and AME-PY. We also acknowledge Ronen Hazan from the Israeli Phage Therapy Center (IPTC) for providing access to the bacteriophage EfGrKN used in this study.
Funding
This study was funded by the KU Leuven Interdisciplinary Networks ID-N grant IDN/20/024/55946278. The funding source had no role in the study design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.
Author information
Author notes
These authors contributed equally: Laura Bessems, Louise Sykora.
These authors jointly supervised this work: Jolien Onsea, Willem-Jan Metsemakers.
Authors and Affiliations
Department of Development and Regeneration, KU Leuven, Leuven, Belgium
Laura Bessems, Louise Sykora, Jolien Onsea & Willem-Jan Metsemakers
Department of Orthopaedic and Trauma Surgery, University Hospitals Leuven, Leuven, Belgium
Laura Bessems, Louise Sykora, Georges Vles, Hazem Wafa, Jolien Onsea & Willem-Jan Metsemakers
Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium
Melissa Depypere
Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
Melissa Depypere & Liesbet Henckaerts
Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium
Yves Debaveye
Pharmacy Department, University Hospitals Leuven, Leuven, Belgium
Isabel Spriet & David Devolder
Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium
Isabel Spriet
Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
Paul De Munter
Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium
Paul De Munter & Liesbet Henckaerts
Institute for Orthopaedic Research and Training (IORT), KU Leuven, Leuven, Belgium
Georges Vles & Hazem Wafa
Laboratory of Gene Technology, Department of Biosystems, KU Leuven, Leuven, Belgium
Rob Lavigne, Stefaan Verwimp & Sabrina Green
Computational Systems Biology, Department of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium
Stefaan Verwimp & Vera Van Noort
Institute of Biology Leiden, Leiden University, Leiden, The Netherlands
Vera Van Noort
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium
Maya Merabishvili & Jean-Paul Pirnay
Interuniversity Institute for Biostatistics (I-BioStat), Hasselt University and KU Leuven, Leuven, Belgium
Geert Molenberghs
Authors
- Laura Bessems
- Louise Sykora
- Melissa Depypere
- Yves Debaveye
- Isabel Spriet
- David Devolder
- Paul De Munter
- Liesbet Henckaerts
- Georges Vles
- Hazem Wafa
- Rob Lavigne
- Stefaan Verwimp
- Vera Van Noort
- Sabrina Green
- Maya Merabishvili
- Jean-Paul Pirnay
- Geert Molenberghs
- Jolien Onsea
- Willem-Jan Metsemakers
Corresponding author
Correspondence to Willem-Jan Metsemakers.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Bessems, L., Sykora, L., Depypere, M. et al. Personalized adjunctive phage therapy for difficult-to-treat musculoskeletal infections. Nat Commun (2026). https://doi.org/10.1038/s41467-026-79305-y
Received: 09 July 2026
Accepted: 15 October 2026
Published: 05 November 2026
DOI: https://doi.org/10.1038/s41467-026-79305-y
来源:Nature 健康护理主题 · nature.com